Mobile Edition
Print
Get the Mag
Weekly UpdatesUK pharma major GlaxoSmithKline (GSK) is making 10m [pounds sterling] available as seed money to support the formation of a new public private partnership approach for paediatric HIV research focused on sub-Saharan Africa, where there are more than 2m children living with HIV/AIDS.
|
More Resources
|
|||
UK pharma major GlaxoSmithKline (GSK) is making 10m [pounds sterling] available as seed money to support the formation of a new
COPYRIGHT 2009 Society of Chemical
Industry Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2009 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company. NOTE: All illustrations and photos have been removed from this article. |
|||
FEED